Does Rallies show 13F holders for MIRA?

Yes. Rallies tracks hedge fund and 13F ownership data for MIRA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MIRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.

MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRA trades at $1.00 with a market cap of $41.01M and a P/E ratio of -0.72. MIRA moved +0.00% today. Year to date, MIRA is -35.06%; over the trailing twelve months it is -26.14%. Its 52-week range spans $0.73 to $2.56. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MIRA stock?

Hedge funds tracked by Rallies that own MIRA include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MIRA Pharmaceuticals, Inc. Common Stock.

MIRA Key Metrics

Key financial metrics for MIRA
Metric	Value
Price	$1.00
Market Cap	$41.01M
P/E Ratio	-0.72
EPS	$-1.35
Dividend Yield	0.00%
52-Week High	$2.56
52-Week Low	$0.73
Volume	415
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-10.44M
Gross Margin	0.00%

Top Hedge Funds Holding MIRA

Citadel Advisors holds 97.98K shares of MIRA, changed +301.61% as of Dec 31, 2024.
Two Sigma holds 15.14K shares of MIRA, changed +26.51% as of Dec 31, 2024.

Latest MIRA News

MIRA Pharmaceuticals Reports Safe Tolerability and Favorable PK in 57-Volunteer Ketamir-2 Phase 1 Trial — May 14, 2026
MIRA Reports SKNY-1 Preclinical Study Showing 30% Weight Loss, Lipid Normalization — May 13, 2026
MIRA's Mira-55 Shows No CNS Side Effects at Up to 100 mg/kg, Supports IND — Mar 23, 2026
MIRA Completes Ketamir-2 Phase 1 Dosing in 56 Volunteers with No Serious AEs — Mar 4, 2026

Recent MIRA Insider Trades

Aminov Erez sold 613.60K (~$1.29M) on Oct 16, 2025.
Aminov Erez sold 44.59K (~$56.63K) on Nov 20, 2024.
Aminov Erez sold 55.41K (~$77.02K) on Nov 19, 2024.

MIRA Analyst Consensus

MIRA analyst coverage data. Average price target: $0.00.

Common questions about MIRA

Who owns MIRA stock?: Hedge funds tracked by Rallies that own MIRA include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MIRA Pharmaceuticals, Inc. Common Stock.
Does Rallies show 13F holders for MIRA?: Yes. Rallies tracks hedge fund and 13F ownership data for MIRA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MIRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.